PREDICTING THE PROBABILITY OF DEVELOPING OBESITY DEPENDING ON LEPTIN AND LEPTIN RECEPTOR POLYMORPHISMS
DOI:
https://doi.org/10.11603/mcch.2410-681X.2024.i1.14597Keywords:
metabolic syndrome, LEP, LEPR genes, allele polymorphismAbstract
Introduction. Metabolic syndrome is a heterogeneous pathological condition that combines different stages of obesity, impaired glucose tolerance, atherogenic dyslipidemia and arterial hypertension. Obesity itself is a key element of this syndrome. Hormonal disorders, the central one of which is insulin resistance, trigger a cascade of neuroendocrine changes that lead to the progression of MetS. Monogenic mutations are often detected in patients with severe obesity, as well as with early (up to 10 years) its debut. In recent years, it has been increasingly investigated for a genetically determined breakdown in the mechanism of leptin's influence on the development of obesity.
The aim of this study – to evaluate the probability of obesity development in patients with LEP and LEPR polymorphisms in Ukrainian population.
Research Methods. 53 obesity and 43 non-obesity patients underwent genotyping of the LEP and LEPR genes (K109R (rs1137100), Q223R (rs1137101), K656N (rs1805094), G2548A (rs7799039)) polymorphism was performed using TaqMan™ SNP Genotyping Human Assays (Thermo Fisher Scientific, USA).
Results and Discussion. Comparing rs1137101 Allele A, rs1137101 Allele G statistically significant differences were revealed, while comparing rs1805094 Allele C, rs1805094 Allele G, rs7799039 Allele A, rs7799039 Allele G, rs1137100 Allele A, rs1137100 Allele G depending on group indicated no statistically significant differences. SNP (rs1137101) Allele A statistically significant differences depending on obesity degree (p < 0.001). Comparing the rest of SNP`s Allele`s (rs1805094 Allele C, rs1805094 Allele G, rs7799039 Allele A, rs7799039 Allele G, rs1137101 Allele G, rs1137100 Allele A, rs1137100 Allele G, rs696217 Allele G) no statistically significant differences was noted. Prediction of the probability of developing obesity depending on the polymorphism of leptin and leptin receptors revealed the dependence of only mutations in LEPR (Q223R (rs1137101)) in the Ukrainian population. According to the results of the ROC analysis sensitivity and specificity of the method were 65.5 % and 67.8 %, respectively.
Conclusions. Our analysis showed that LEPR Q223R (rs1137101) polymorphism could be a potential genetic risk factor for obesity in Ukrainian population regardless of the homozygous or heterozygous genotype (genotypes AA, AG, GG). At the same time, allele A was found in 70.83 % of cases of patients with 2nd and 3rd degree obesity. And homozygous AA and GG genotypes in 24.5 % and 28.3 %, respectively. The results obtained can be used in the practice for early diagnosis of different types of obesity and for prognosing of results of bariatric surgery.
References
Lonardo, A. (2023). The heterogeneity of metabolic syndrome presentation and challenges this causes in its pharmacological management: a narrative review focusing on principal risk modifiers. Expert Review of Clinical Pharmacology, 16 (10), 891-911. DOI: 10.1080/ 17512433.2023.2259306
Fahed, G., Aoun, L., Bou Zerdan, M., Allam, S., Bou Zerdan, M., Bouferraa, Y., & Assi, H.I. (2022). Metabolic syndrome: updates on pathophysiology and management in 2021. International Journal of Molecular Sciences, 23(2), 786. DOI: 10.3390/ijms23020786
da Silva, A.A., do Carmo, J.M., Li, X., Wang, Z., Mouton, A.J., & Hall, J.E. (2020). Role of hyperinsulinemia and insulin resistance in hypertension: metabolic syndrome revisited. Canadian Journal of Cardiology, 36(5), 671-682. DOI: 10.1016/j.cjca.2020.02.066
Scheja, L., & Heeren, J. (2019). The endocrine function of adipose tissues in health and cardiometabolic disease. Nature Reviews Endocrinology, 15(9), 507-524. DOI: 10.1038/s41574-019-0230-6
Izquierdo, A.G., Crujeiras, A.B., Casanueva, F.F., & Carreira, M.C. (2019). Leptin, obesity, and leptin resistance: where are we 25 years later? Nutrients, 11(11), 2704. DOI: 10.3390/nu11112704
Anjum, T., Arif, Z., Dar, M., Raza, A., & Bibi, Z. (2021). Leptin: Mechanisms Involved In Signaling and Resistance. Journal of Pharmaceutical Research & Reports, (2)4, 2-5. DOI: 10.47363/JPRSR/2021
Mazen, I.H., El-Gammal, M.A., Elaidy, A.A., Anwar, G.M., Ashaat, E.A., Abdel-Ghafar, S.F., & Abdel-Hamid, M.S. (2023). Congenital leptin and leptin receptor deficiencies in nine new families: identification of six novel variants and review of literature. Molecular Genetics and Genomics, 1-11. DOI: 10.1007/s00438-023-02025-1
Nunziata, A., Funcke, J.B., Borck, G., von Schnurbein, J., Brandt, S., Lennerz, B., ... & Wabitsch, M. (2019). Functional and phenotypic characteristics of human leptin receptor mutations. Journal of the Endocrine Society, 3(1), 27-41. DOI: 10.1210/js.2018-00123
Kleinendorst, L., Abawi, O., van der Kamp, H.J., Alders, M., Meijers-Heijboer, H.E., van Rossum, E.F., ... & van Haelst, M.M. (2020). Leptin receptor deficiency: a systematic literature review and prevalence estimation based on population genetics. European Journal of Endocrinology, 182 (1), 47-56. DOI: 10.1530/EJE-19-0678
Yupanqui-Lozno, H., Bastarrachea, R.A., Yupanqui-Velazco, M.E., Alvarez-Jaramillo, M., Medina-Méndez, E., Giraldo-Peña, A.P., ... & Celis-Regalado, L.G. (2019). Congenital leptin deficiency and leptin gene missense mutation found in two colombian sisters with severe obesity. Genes, 10(5), 342. DOI: 10.3390/genes10050342
Saeed, S., Bonnefond, A., Manzoor, J., Shabir, F., Ayesha, H., Philippe, J., ... & Froguel, P. (2015). Genetic variants in LEP, LEPR, and MC4R explain 30% of severe obesity in children from a consanguineous population. Obesity, 23(8), 1687-1695. DOI: 10.1002/oby.21142
The World Medical Association. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects [Internet]. Available from: https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/
Wasim, M., Awan, F.R., Najam, S.S., Khan, A.R., & Khan, H.N. (2016). Role of leptin deficiency, inefficiency, and leptin receptors in obesity. Biochemical Genetics, 54, 565-572. DOI: 10.1007/s10528-016-9751-z
Baxter, J., Armijo, P.R., Flores, L., Krause, C., Samreen, S., & Tanner, T. (2019). Updates on monogenic obesity in a multifactorial disease. Obesity Surgery, 29, 4077-4083. DOI: 10.1007/s11695-019-04200-z
Hastuti, P., Zukhrufia, I., Padwaswari, M.H., Nuraini, A., & Sadewa, A.H. (2016). Polymorphism in leptin receptor gene was associated with obesity in Yogyakarta, Indonesia. Egyptian Journal of Medical Human Genetics, 17(3), 271-276. DOI: 10.1016/j.ejmhg. 2015.12.011
Illangasekera, Y.A., Kumarasiri, P.V.R., Fernando, D.J., & Dalton, C.F. (2020). Association of the leptin receptor Q223R (rs1137101) polymorphism with obesity measures in Sri Lankans. BMC Research Notes, 13(1), 1-4. DOI: 10.1186/s13104-020-4898-4
Shramko, I.I., Ageeva, E.S., Maliy, K.D., Repinskaya, I.N., Tarimov, C.O., Fomochkina, I.I., ... & Shekhar, S. (2022). Association between Adiponectin and Leptin Receptor Genetic Polymorphisms and Clinical Manifestations of Metabolic Syndrome. Journal of Diabetes Research, 2022. DOI: 10.1155/2022/9881422
Foucan, L., Bassien-Capsa, V., Rambhojan, C., Lacorte, J.M., & Larifla, L. (2019). Influence of K656N polymorphism of the leptin receptor gene on obesity-related traits in nondiabetic Afro-Caribbean individuals. Metabolic Syndrome and Related Disorders, 17(4), 197-203. DOI: 10.1089/met.2018.0133
El Fessikh, M., Elkarhat, Z., Flatters, D., Camproux, A.C., Belghiti, H., Guerinech, H., ... & El Baghdadi, J. (2023). Association study of leptin receptor polymorphisms in women with obesity and their impact on protein domains: a case-control study and in silico analyses. Journal of Biomolecular Structure and Dynamics, 41(14), 6546-6558. DOI: 10.1080/07391102. 2022.2109755
Ali, E.M., Diab, T., Elsaid, A., Abd El Daim, H.A., Elshazli, R.M., & Settin, A. (2021). Fat mass and obesity-associated (FTO) and leptin receptor (LEPR) gene polymorphisms in Egyptian obese subjects. Archives of Physiology and Biochemistry, 127(1), 28-36. DOI: 10. 1080/13813455.2019.1573841
Ortega, F.L., Camberos, A.M., Arredondo, M.I., Magallanes, N.G., & Meraz, E.A. (2023). LEP (G2548A-G19A) and ADIPOQ (T45G-G276T) gene polymorphisms are associated with markers for metabolic syndrome. Diabetology & Metabolic Syndrome, 15(1), 237.
DOI: 10.1186/s13098-023-01215-6
Constantin, A., Costache, G., Sima, A.V., Glavce, C.S., Vladica, M., & Popov, D.L. (2010). Leptin G-2548A and leptin receptor Q223R gene polymorphisms are not associated with obesity in Romanian subjects. Biochemical and Biophysical Research Communications, 391(1), 282-286. DOI: 10.1016/j.bbrc.2009.11.050
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Medical and Clinical Chemistry
This work is licensed under a Creative Commons Attribution 4.0 International License.
